PT - JOURNAL ARTICLE AU - Rizzo, Toni ED - Giugliano, Robert P. ED - Blazing, Michael A. TI - IMPROVE-IT Findings DP - 2015 Nov 21 TA - MD Conference Express PG - 21--22 VI - 15 IP - 28 4099 - http://mdc.sagepub.com/content/15/28/21.short 4100 - http://mdc.sagepub.com/content/15/28/21.full AB - The IMPROVE-IT trial showed that the cholesterol-lowering drug ezetimibe, when added to simvastatin, provides greater improvement in cardiovascular outcomes among patients with diabetes vs those without diabetes in a population with acute coronary syndrome. Additionally, the rate of new-onset diabetes was not increased among patients treated with ezetimibe.